Cancer-cell-secreted CXCL11 promoted CD8+ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC

Second-Line Chemotherapy and Beyond for Non–Small Cell Lung Cancer

(2017) Greg Durm et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity

(2017) Akash Patnaik et al.   Cancer Discovery

Role of CXC group chemokines in lung cancer development and progression

(2017) Artjoms Spaks   Journal of Thoracic Disease

CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer

(2017) Jieyao Li et al.   OncoImmunology

Calreticulin Expression in Human Non–Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis

(2016) Jitka Fucikova et al.   CANCER RESEARCH

HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins

(2016) Damien Bertheloot et al.   Cellular & Molecular Immunology

Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells

(2016) Naoki Horikawa et al.   CLINICAL CANCER RESEARCH

ROS-dependent HMGB1 secretion upregulates IL-8 in upper airway epithelial cells under hypoxic condition

(2016) H J Min et al.   Mucosal Immunology

Cytoplasmic expression of high mobility group B1 (HMGB1) is associated with tumor-infiltrating lymphocytes (TILs) in breast cancer

(2016) Hee Jin Lee et al.   PATHOLOGY INTERNATIONAL

Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy

(2016) Ruth Exner et al.   Cancer Medicine

A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial

(2015) K. Kubota et al.   ANNALS OF ONCOLOGY

CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma

(2015) J Y Liu et al.   BRITISH JOURNAL OF CANCER

HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway

(2015) Weijun Liu et al.   CANCER BIOLOGY & THERAPY

Prognostic factors in non-small cell lung cancer patients who are recommended to receive single-agent chemotherapy (docetaxel or pemetrexed) as a second- or third-line chemotherapy: in the era of oncogenic drivers and molecular-targeted agents

(2015) Takehito Shukuya et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Phenotypic characterization and anti-tumor effects of cytokine-induced killer cells derived from cord blood

(2015) Zhen Zhang et al.   CYTOTHERAPY

TGF-β Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2/3 and Suppression of HGF/c-Met Signaling Mechanisms

(2015) Wei Bin Fang et al.   PLoS One

CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy

(2015) Zuqiang Liu et al.   OncoImmunology

Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells

(2015) Peter S. Fenwick et al.   PLoS One

Apicidin and Docetaxel Combination Treatment Drives CTCFL Expression and HMGB1 Release Acting as Potential Antitumor Immune Response Inducers in Metastatic Breast Cancer Cells

(2015) Maria Buoncervello et al.   NEOPLASIA

Macrophage Inflammatory Protein Derivative ECI301 Enhances the Alarmin-Associated Abscopal Benefits of Tumor Radiotherapy

(2014) S. Kanegasaki et al.   CANCER RESEARCH

HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma

(2014) Banzhou Pan et al.   Molecular Cancer

HMGB1 in Cancer: Good, Bad, or Both?

(2013) R. Kang et al.   CLINICAL CANCER RESEARCH

Plasma HMGB-1 after the initial dose of epirubicin/docetaxel in cancer

(2013) Tobias Arnold et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

IL-6 Trans-Signaling Enhances CCL20 Production from IL-1β-Stimulated Human Periodontal Ligament Cells

(2013) Yoshitaka Hosokawa et al.   INFLAMMATION

Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death

(2013) James W. Hodge et al.   INTERNATIONAL JOURNAL OF CANCER

Enhancement of antigen-specific CD8 T cell responses by co-delivery of Fc-fused CXCL11

(2013) Hong Namkoong et al.   VACCINE

Tissue Damage-Associated "Danger Signals" Influence T-cell Responses That Promote the Progression of Preneoplasia to Cancer

(2012) Y. He et al.   CANCER RESEARCH

Regulation of CCL20 expression in astrocytes by IL-6 and IL-17

(2012) Gordon P. Meares et al.   GLIA

The IKK -Dependent NF- B p52/RelB Noncanonical Pathway Is Essential To Sustain a CXCL12 Autocrine Loop in Cells Migrating in Response to HMGB1

(2012) R. R. Kew et al.   JOURNAL OF IMMUNOLOGY

The Expression of High Mobility Group Box 1 is Associated with Lymph Node Metastasis and Poor Prognosis in Esophageal Squamous Cell Carcinoma

(2012) Chen Chuangui et al.   PATHOLOGY & ONCOLOGY RESEARCH

HMGB1 and RAGE in Inflammation and Cancer

(2010) Gary P. Sims et al.   Annual Review of Immunology

Tumor Ablation by Gene-Modified T Cells in the Absence of Autoimmunity

(2010) L. X. J. Wang et al.   CANCER RESEARCH

CXC Chemokine Ligand (CXCL) 9 and CXCL10 Are Antagonistic Costimulation Molecules during the Priming of Alloreactive T Cell Effectors

(2010) J. M. Rosenblum et al.   JOURNAL OF IMMUNOLOGY

Regulation of Toll-like receptor-induced chemokine production in murine dendritic cells by mitogen-activated protein kinases

(2010) Daniel Mitchell et al.   MOLECULAR IMMUNOLOGY

Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells

(2009) Lara Campana et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Combination of Docetaxel and Recombinant Vaccine Enhances T-Cell Responses and Antitumor Activity: Effects of Docetaxel on Immune Enhancement

(2008) C. T. Garnett et al.   CLINICAL CANCER RESEARCH